Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-26-006422

Chief Scientific Officer sold 4,170 shares at $15.01 ($62,585)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lorrain Daniel S. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form 10b5-1 −4,170 $15.01 $62,585 151,882 D
Open-market sales · 4,170 sh · avg $15.01 · $62,585
Loading xslF345X05/rdgdoc.xml…